Home > Insider Trading > Filing (0001209191-16-126264)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1539029	Clearside Biomedical Inc.	CLSD	Pharmaceutical Preparations (2834)	452437375

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579466	Rusnanomedinvest Llc	44, Bldg. 1, Krasnobogatyrskaya Street Moscow 1Z 107076		No	No	Yes	No
1579787	S.a.r.l. Investments Rmi	7, Robert Stumper Grand Duchy N4 L-2557		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-07	1,179,398	$0.00	1,515,167	No	4	C	Direct
Common Stock	Acquisiton	2016-06-07	42,857	$7.00	1,558,024	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2016-06-07	2,594,677	$0.00	1,179,398	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Represents shares received upon conversion of shares of Series B Preferred Stock.
Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series B Preferred Stockautomatically converted into 0.454545 shares of the Issuer's common stock. The Series B Preferred Stock had no expiration date.
The Reporting Person is a wholly-owned subsidiary of Rusnano MedInvest LLC ("RMI LLC"). RMI LLC is the beneficiary of the Reporting Person.